Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart patch put to the test in 500-Person wearability trial

NCT ID NCT07388355

Not yet recruiting Knowledge-focused Sponsor: Wearlinq Source: ClinicalTrials.gov ↗

Summary

This study aims to see how easy and comfortable it is for people to wear a new heart-monitoring patch called the WearLinq eWave. About 500 adults, including some with heart conditions and some who are healthy, will wear the patch on their chest for 7 days, with some wearing it for up to 30 days. Researchers will track how long the patch stays on and if it causes any skin irritation or other problems.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • ABio Clinical Research Partners

    New London, North Carolina, 28127, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.